Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesLittle evidence that supports a causal link between most vaccines and Guillain-Barre syndrome
Drugs & Therapy Perspectives, 10/16/09
Immune stimulation appears to play a role in the pathogenesis of Guillain–Barre syndrome (GBS). It is, therefore, biologically plausible that immunizations may be associated with subsequent GBS. In a recent review of the current body of evidence, associations between vaccines and GBS were generally found to have been only temporal, with little evidence to support a causal association with most vaccines.
Related Articles
Cardiovascular Complications of the Guillain-Barré Syndrome
The American Journal of Cardiology, 11/10/09
Relevance Score: 65%
Guillain–Barre syndrome: update on immunobiology and treatment
Expert Review of Neurotherapeutics, 10/06/09
Relevance Score: 65%
Successful Treatment With Sumatriptan in a Case With Cyclic Vomiting Syndrome Combined With 18q– Syndrome
Journal of Child Neurology, 10/02/09
Relevance Score: 47%
Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09
Relevance Score: 46%
Adult-onset Still’s disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood
Zeitschrift für Rheumatologie, 10/29/09
Relevance Score: 46%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09
Efficacy and Safety of Pentavalent Human-Bovine Reassortant Rotavirus Vaccine When Administered With Greater Than 10 Weeks Between Doses
The Pediatric Infectious Disease Journal, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor